From: Validation of a novel point of care testing device for sickle cell disease
Sensitivity (95 % CI) | Specificity (95 % Cl) | |
---|---|---|
SCD (HbSS, HbSC, HbSβ+-thal, HbSβ0-thal) | 100 % (91–100) | 100 % (90–100) |
Sickle trait (HbAS) | 100 % (85–100) | 98 % (90–100) |
C trait (HbAC) | 100 % (44–100) | 100 % (95–100) |
Normal (HbAA) | 100 % (68–100) | 100 % (94–100) |